BVMF/ABBV34 (BVMF/ABBV34)

Brazil Stock Exchange: BVMF/ABBV34 · BRL

R$95.5

-1.52 (-1.6%)· Recorded snapshot

Market cap	2.7T
Revenue (ttm)	333.6B
Net income (ttm)	32.5B
EPS (ttm)	R$1.18
P/E (trailing)	81.1x
P/E (forward)	19.1x
Dividend	R$1.47 (1.54%)
Volume	1,239
Beta	0.23

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 333.6B
Net income (ttm): 32.5B
EPS (ttm): R$1.18
P/E (trailing): 81.1x
P/E (forward): 19.1x
Market cap: 2.7T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.1

P25 n/aP50 n/aP75 n/a

Trailing P/E81.1

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/ABBV34 indicators

Market & fundamental data

Available fields

251

Groups with data

Currency

USD

Showing 251 of 251 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-30
Employees	57,000
Employees change	2,000
Employees growth	3.64%
Enterprise value	BRL 3.1T
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2012
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	BRABBVBDR001
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Last stock split date	2022-11-21
Last stock split type	Forward
Market cap	BRL 2.7T
Next earnings date	2026-10-30
Price	BRL 95.50
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bvmf/ABBV34
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	41.3x
Average P/E ratio (3Y)	81.44x
Average P/E ratio (5Y)	58.76x
Earnings yield	1.23%
EV/Earnings	93.9x
EV/EBIT	24.92x
EV/EBITDA	18.31x
EV/FCF	32.33x
EV/Sales	8.86x
FCF / EV yield	3.09%
FCF yield	3.49%
Forward P/E	19.06x
Lynch fair value	BRL 5.73
Lynch upside	-94%
P/(FCF - SBC) ratio	30.31x
P/(OCF - SBC) ratio	28.19x
P/E ratio	81.1x
P/FCF ratio	28.68x
P/OCF ratio	26.78x
P/S ratio	8.11x
Price/EBITDA ratio	16.98x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.56%
EBITDA margin	47.78%
Effective tax rate	27.39%
FCF margin	27.53%
Gross margin	72.79%
Operating margin	35.56%
Pretax margin	13.51%
Profit margin	9.8%
Profit per employee	BRL 569,888
Profitable quarters	6
Profitable years	17
Revenue per employee	BRL 5.9M
ROA	10.51%
ROA (5Y)	8.68%
ROCE	24.49%
ROE (5Y)	1,295.17%
ROIC	17.7%
ROIC (5Y)	21.99%
SBC / revenue	1.52%
Tax / revenue	3.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	68.54%
EPS growth (Q)	290.39%
EPS growth (QoQ)	422.72%
EPS growth 10Y	0.21%
EPS growth 3Y	-10.05%
EPS growth 5Y	-0.92%
EPS growth quarters	1
EPS growth years	0
FCF growth	-0.16%
FCF growth (Q)	-36.24%
FCF growth (QoQ)	-12.63%
FCF growth 3Y	-9.78%
FCF growth 5Y	-1.43%
Gross profit growth	12.78%
Gross profit growth (Q)	14.64%
Gross profit growth 3Y	5.88%
Gross profit growth 5Y	5.07%
Net income growth	67.69%
Net income growth (Q)	285.18%
Net income growth (QoQ)	424.16%
Net income growth 3Y	-10.12%
Net income growth 5Y	-1.02%
Net income growth quarters	1
Net income growth years	0
OCF growth	1.16%
OCF growth (Q)	-33.32%
OCF growth (QoQ)	-10.26%
OCF growth 10Y	9.1%
OCF growth 3Y	-8.59%
OCF growth 5Y	-0.94%
Operating income growth	21.17%
Operating income growth (Q)	17.54%
Operating income growth 3Y	3.56%
Operating income growth 5Y	3.75%
Revenue growth	10.39%
Revenue growth (Q)	10.16%
Revenue growth (QoQ)	13.25%
Revenue growth 10Y	10.03%
Revenue growth 3Y	4.75%
Revenue growth 5Y	3.69%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -6.7B
Depreciation and amortization	BRL 41.9B
EBIT	BRL 118.6B
EBITDA	BRL 159.4B
EPS	BRL 1.18
Financing cash flow	BRL -66.8B
Free cash flow	BRL 94.3B
Free cash flow minus SBC	BRL 89.3B
Gross profit	BRL 242.8B
Income taxes	BRL 12.3B
Investing cash flow	BRL -33.7B
Net borrowing	BRL 2.2B
Net cash flow	BRL 528.4M
Net income	BRL 32.5B
Operating cash flow minus SBC	BRL 96B
Operating income	BRL 118.6B
Revenue	BRL 333.6B
Stock-based compensation	BRL 5.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.42
Book value per share	BRL -17.40
Debt / EBITDA	2.28
Debt / FCF	3.89
Goodwill	BRL 189.1B
Interest coverage	7.85
Long-term assets	BRL 520.8B
Long-term liabilities	BRL 508.9B
Net cash (debt)	BRL -333.2B
Net cash / market cap	-12.31%
Net debt / EBITDA	2.09
Net debt / FCF	3.53
Piotroski F-Score	8
Property, plant and equipment	BRL 30.9B
Shareholders' equity	BRL -30.5B
Tangible book value	BRL -469.3B
Tangible book value per share	BRL -265.61
Total assets	BRL 700B
Total cash	BRL 34B
Total debt	BRL 367.2B
Total liabilities	BRL 730.5B
WACC	5.2%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	BRL 179.2B
Current liabilities	BRL 221.7B
Current ratio	0.81
Inventory turnover	3.47
Net working capital	BRL -32.1B
Quick ratio	0.49
Working capital	BRL -41.3B
Working capital turnover	-36.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.03%
Dividend growth	8.86%
Dividend growth (10Y)	23.17%
Dividend growth (3Y)	4.84%
Dividend growth (5Y)	5.83%
Dividend growth years	6
Dividend payment date	2026-11-23
Dividend payment years	11
Dividend payout frequency	Quarterly
Dividend per share	BRL 1.47
Dividend yield	1.54%
Ex-dividend date	2026-10-14
Last dividend	BRL 0.07
Payout ratio	189.83%
Shareholder yield	1.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	702.05%
10Y return CAGR	26.92%
10Y total return	984.7%
150-day SMA	BRL 76.85
1D price change	-1.57%
1M price change	11.34%
1M total return	11.81%
1W price change	6.49%
1W total return	6.49%
1Y price change	24.5%
1Y return CAGR	27.01%
1Y total return	26.98%
20-day SMA	BRL 88.41
200-day SMA	BRL 75.80
3M price change	16.48%
3M total return	16.96%
3Y price change	109.89%
3Y return CAGR	30.91%
3Y total return	124.4%
50-day SMA	BRL 85.80
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 97.74
52-week high date	2026-10-27
52-week low	BRL 58.81
52-week low date	2026-04-29
5Y price change	151.63%
5Y return CAGR	23.15%
5Y total return	183.17%
6M price change	54.46%
6M total return	55.85%
All-time high	BRL 97.74
All-time high date	2026-10-27
All-time low	BRL 11.70
All-time low date	2017-02-14
Average true range (ATR)	BRL 3.07
Average volume	1.3K
Beta (5Y)	0.23
Change from 52-week high	-2.29%
Change from 52-week low	62.39%
Change from all-time high	-2.29%
Change from all-time low	716.38%
Change from open	-2.29%
Day's gap	0.74%
Dollar volume	BRL 118,325
High price	BRL 97.74
Low price	BRL 94.80
Monthly RSI	71.93
Open price	BRL 97.74
Position in 52-week range	23.81%
Previous close	BRL 97.02
Price vs 150-day SMA	24.27%
Price vs 20-day SMA	8.03%
Price vs 200-day SMA	26%
Price vs 50-day SMA	11.3%
Relative volume	0.92
RSI	66.72
Sharpe ratio	0.67
Sharpe ratio (3Y)	0.84
Sharpe ratio (5Y)	0.73
Sortino ratio	1.15
Sortino ratio (3Y)	1.41
Sortino ratio (5Y)	1.26
Volume	1.2K
Weekly RSI	71.92
YTD price change	21.07%
YTD total return	23.49%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.23%
Shares change (YoY)	0.03%
Shares held by insiders	0.07%
Shares held by institutions	76.58%
Short ratio	3.2 days

Deeper analysis on BVMF/ABBV34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/ABBV34 report

Is a complete BVMF/ABBV34 research report available?

No complete published report is available for bvmf/ABBV34 (BVMF/ABBV34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/ABBV34 (BVMF/ABBV34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/ABBV34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/ABBV34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/ABBV34

Frequently asked questions